-->

Tag: FDA-approved targeted therapy

Home / FDA-approved targeted therapy

Categories

Alectinib has been approved by the USFDA as adjuvant treatment for ALK-positive non-small cell lung cancer

Alectinib approved in the treatment of non-small cell lung cancer The Food and Drug Administration (FDA) has approved the drug Alecensa, made by Genentech, Inc. It can be used as an extra treatment f...
fda-approved-targeted-therapy

Erdafitinib is approved by USFDA for locally advanced or metastatic urothelial carcinoma

Erdafitinib (Balversa, Janssen Biotech) was approved by the Food and Drug Administration on January 19, 2024, for adult patients with FGFR3 genetic changes who have locally advanced or metastatic uro...
fda-approved-targeted-therapy

Scan the code